NiteCAPP_HELPS_WD: Improving Sleep and Reducing Opioid Use in Chronic Pain Patients
Key facts
- Who runs it
- University of Missouri-Columbia
- Where
- Columbia, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 31 Mar 2022
- Ended
- 1 Jun 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- NiteCAPP HELPS
- Tapered Withdrawal
- Record updated
- 5 August 2024
- Why it stopped
- NIDA R01 Awarded
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- 18+ yrs old
- willing to be randomized
- can read/understand English
- diagnosed with chronic widespread pain and insomnia
- prescribed opioid medication for 1+ mo, 3+ times per week
- desire to reduce or eliminate opioid use
- written agreement from physician prescribing opioid medication
- no prescribed or OTC sleep meds for 1+ mo, or stabilized for 6+ wks
Who cannot take part
- psychotropic or other medications (e.g., beta-blockers) that alter pain or sleep (medications prescribed for pain or sleep are allowed)
- <6 mos post back surgery
- cognitive impairment (MMSE <26)
- sleep disorder other than insomnia [i.e., sleep apnea (apnea/hypopnea index, AHI >15), Periodic Limb Movement Disorder (myoclonus arousals per hour >15)]
- bipolar or seizure disorder (due to risk of sleep restriction treatment)
- other severe, untreated major psychopathology except depression or anxiety (e.g., suicidal ideation/intent, psychotic disorders)
- other spinal disorders
- unable to provide informed consent
- participation in other non-pharmacological treatment for pain, sleep, or mood outside current Internal metal objects or electrical devices
- pregnancy
- presumptive/confirmed lumbar nerve root compression
- confirmed lumbar spinal stenosis
Where in United States
- University of Missouri - ColumbiaColumbia, United States
About the trial
What the trial wants to find out
This project addresses the highly significant problem of developing effective strategies for facilitating withdrawal from opioid medications. The proposed work is conceptualized within the context of a well-known theoretical framework (Cognitive Activation Theory of Stress), and the research questions are theory-driven. The team proposes to evaluate an innovative web-based version of CBT-I followed by tapered withdrawal in a randomized trial in comparison to a Treatment As Usual control followed by tapered withdrawal. The dependent measures have been well-selected to effectively evaluate the outcomes. The methodological details are rigorous.
The 2 groups in the trial
- NiteCAPP HELPSTreatment being tested
4 weeks of online CBT-I (1 session/week for 1 hour), followed by tapered withdrawal and motivational interviewing and check-ins.
Treatment: NiteCAPP HELPS and Tapered Withdrawal
- Treatment as UsualOther group
Continuation of standard treatment for sleep and pain for 4 weeks, followed by tapered withdrawal and motivational interviewing and check-ins.
Treatment: Tapered Withdrawal
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain on Central Pain Processing
- Record updated
- 5 August 2024